Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of spiroisoquinolinone derivatives of Formula I.
As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
Type:
Grant
Filed:
June 2, 2000
Date of Patent:
February 19, 2002
Assignee:
Bristol-Myers Squibb Company
Inventors:
Graham S. Poindexter, Ildiko Antal, Leah M. Giupponi, Robert H. Stoffel, Marc A. Bruce